Deutsch English Français

Contact

EP1141238

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1141238

EP1141238 - PRODUCTION OF PROTEINS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 09.12.2005 Database last updated on 25.09.2024
Most recent event Tooltip	28.03.2008	Lapse of the patent in a contracting state New state(s): PT	published on 30.04.2008 [2008/18]
Applicant(s)	For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN / GB
	[N/P]
Former [2005/05]	For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 ONN / GB
Former [2001/41]	For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 ONN / GB
Inventor(s)	01 / ISLAM, Seema, Glaxo Wellcome plc Langley Court, South Eden Park Road Beckenham, Kent BR3 3BS / GB
	02 / SHARP, Nigel Alan, Glaxo Wellcome plc Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB
	[2004/40]
Former [2001/41]	01 / ISLAM, Seema, Glaxo Welcome plc Langley Court, South Eden Park Road Beckenham, Kent BR3 3BS / GB
	02 / SHARP, Nigel Alan, Glaxo Welcome plc Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB
Representative(s)	Filler, Wendy Anne, et al GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB
	[N/P]
Former [2001/41]	Filler, Wendy Anne, Dr., et al GlaxoSmithKline Corporate Intellectual Property Two New Horizons Court Brentford, Middlesex TW8 9EP / GB
Application number, filing date	99965506.1	21.12.1999
	[2001/41]
	WO1999EP10157
Priority number, date	GB19980028624	23.12.1998 Original published format: GB 9828624
	[2001/41]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO0039282
	Date:	06.07.2000
	Language:	EN
	[2000/27]
	Type:	A1 Application with search report
	No.:	EP1141238
	Date:	10.10.2001
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 06.07.2000 takes the place of the publication of the European patent application.
	[2001/41]
	Type:	B1 Patent specification
	No.:	EP1141238
	Date:	02.02.2005
	Language:	EN
	[2005/05]
Search report(s)	International search report - published on:	EP	06.07.2000
Classification	IPC:	C12N1/38, C12N5/00, C12P21/02	[2001/41]
	CPC:	C12N5/0018 (EP,US); C12N1/38 (EP,US); C12N2500/36 (EP,US)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/41]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	HERSTELLUNG VON PROTEINEN	[2004/31]
	English:	PRODUCTION OF PROTEINS	[2001/41]
	French:	PRODUCTION DE PROTEINES	[2001/41]
	Former [2001/41]	HESTELLUNG VON PROTEINEN
Entry into regional phase	25.06.2001	National basic fee paid
	25.06.2001	Designation fee(s) paid
	25.06.2001	Examination fee paid
Examination procedure	13.07.2000	Request for preliminary examination filed International Preliminary Examining Authority: EP
	25.06.2001	Examination requested [2001/41]
	21.11.2003	Despatch of a communication from the examining division (Time limit: M04)
	06.01.2004	Reply to a communication from the examining division
	27.01.2004	Despatch of a communication from the examining division (Time limit: M04)
	14.05.2004	Reply to a communication from the examining division
	19.08.2004	Communication of intention to grant the patent
	29.10.2004	Fee for grant paid
	29.10.2004	Fee for publishing/printing paid
Opposition(s)	03.11.2005	No opposition filed within time limit [2006/04]
Fees paid	Renewal fee
	13.12.2001	Renewal fee patent year 03
	12.12.2002	Renewal fee patent year 04
	03.12.2003	Renewal fee patent year 05
	03.12.2004	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	02.02.2005
	CH	02.02.2005
	FI	02.02.2005
	LI	02.02.2005
	NL	02.02.2005
	DK	02.05.2005
	GR	02.05.2005
	SE	02.05.2005
	PT	02.07.2005
	[2008/18]
Former [2006/22]	AT	02.02.2005
	CH	02.02.2005
	FI	02.02.2005
	LI	02.02.2005
	NL	02.02.2005
	DK	02.05.2005
	GR	02.05.2005
	SE	02.05.2005
Former [2006/14]	AT	02.02.2005
	CH	02.02.2005
	FI	02.02.2005
	LI	02.02.2005
	DK	02.05.2005
	GR	02.05.2005
	SE	02.05.2005
Former [2006/12]	AT	02.02.2005
	CH	02.02.2005
	FI	02.02.2005
	LI	02.02.2005
	DK	02.05.2005
	SE	02.05.2005
Former [2005/51]	AT	02.02.2005
	FI	02.02.2005
	SE	02.05.2005
Former [2005/48]	FI	02.02.2005
	SE	02.05.2005
Former [2005/46]	FI	02.02.2005
Cited in	International search	[DA]EP0239292 (CELLTECH LTD [GB]) [DA] * the whole document *;
		[DA]WO8906686 (UPJOHN CO [US]) [DA] * the whole document *;
		[DA]US5378612 (NAKASHIMA KAZUYUKI [JP], et al) [DA] * the whole document *;
		[A]WO9639488 (GENENTECH INC [US], et al) [A] * the whole document *;
		[A] - CHOTIGEAT W ET AL, "ROLE OF ENVIRONMENTAL CONDITIONS ON THE EXPRESSION LEVELS, GLYCOFORM PATTERN AND LEVELS OF SIALYLTRANSFERASE FOR HFSH PRODUCEDBY RECOMBINANT CHO CELLS", CYTOTECHNOLOGY,NL,KLUWER ACADEMIC PUBLISHERS, DORDRECHT, (19940101), vol. 15, no. 1/03, ISSN 0920-9069, pages 217 - 221, XP000602299 [A] * the whole document * DOI: http://dx.doi.org/10.1007/BF00762396
		[A] - D.P. PALERMO ET AL., "Production of analytical quantities of recombinant proteins in Chinese hamster overy cells using sodium butyrate to elevate gene expression", J. BIOTECHNOLOGY, ELSEVIER, AMSTERDAM,NL, (199106), vol. 19, no. 1, pages 35 - 48, XP002135791 [A] * the whole document * DOI: http://dx.doi.org/10.1016/0168-1656(91)90073-5
		[A] - GOLDSTEIN S ET AL, "ENHANCED TRANSFECTION EFFICIENCY AND IMPROVED CELL SURVIVAL AFTER ELECTROPORATION OF G2/M-SYNCHRONIZED CELLS AND TREATMENT WITH SODIUM BUTYRATE", NUCLEIC ACIDS RESEARCH,GB,OXFORD UNIVERSITY PRESS, SURREY, (19890101), vol. 17, no. 10, ISSN 0305-1048, pages 3959 - 3971, XP002054817 [A] * the whole document *
		[DA] - GORMAN C M ET AL, "EXPRESSION OF RECOMBINANT PLASMIDS IN MAMMALIAN CELLS IS ENHANCED BY SODIUM BUTYRATE", NUCLEIC ACIDS RESEARCH,GB,OXFORD UNIVERSITY PRESS, SURREY, (19830101), vol. 11, no. 21, ISSN 0305-1048, pages 7631 - 7648, XP002054816 [DA] * the whole document *
		[DA] - C.R. BEBBINGTON ET AL., "High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker", NATURE BIOTECHNOLOGY, NATURE PUBL. CO.,NEW YORK, US, (199202), vol. 10, pages 169 - 175, XP002135792 [DA] * the whole document * DOI: http://dx.doi.org/10.1038/nbt0292-169

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p